Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Xention
company
About
Xention Limited is a biopharmaceutical company specialized in the discovery and development of ion channel-modulating drugs.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- £4M
- Industries
- Biotechnology,Developer Platform,Medical
- Founded date
- Jan 1, 2002
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Xention Limited, a biopharmaceutical company, specializes in the discovery and development of ion channel-modulating drugs. It offers drugs for the treatment of atrial fibrillation, overactive bladder, pain, and autoimmune diseases. Xention Limited was formerly known as Xention Discovery Ltd. and later changed its name to Xention Limited in October 2006. The company was founded in 2002 and is based in Cambridge, the United Kingdom.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
£4M €11M
Xention has raised a total of
£4M €11M
in funding over 2 rounds. Their latest funding was raised on
Jul 18, 2005 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 18, 2005 | Series B | €11M | 1 | — | — | Detail |
| Sep 10, 2003 | Series Unknown | £4M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Xention is funded by 1 investors.
Albany Ventures Fund III
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
